Annual overview

(Thomson Reuters ONE) -


Issuers of listed transferable securities are required to provide
Oslo Stock Exchange with an annual summary of information made
available to the public, cf the Stock Exchange Regulations, section
5-2, §5.

Please find the annual overview for Pronova BioPharma ASA (OSE:
PRON.OL) attached. The overview includes all announcements made
available in 2009.

This information is subject of the disclosure requirements acc. to §5-12 vphl
(Norwegian Securities Trading Act)

This announcement was originally distributed by Hugin. The issuer is
solely responsible for the content of this announcement.



[HUG#1408752]





Annual overview 2009: http://hugin.info/137506/R/1408752/361384.pdf

Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: hugin
Datum: 27.04.2010 - 14:26 Uhr
Sprache: Deutsch
News-ID 19761
Anzahl Zeichen: 0

contact information:
Town:

Lysaker

Kategorie:

Business News

Diese Pressemitteilung wurde bisher 188 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Annual overview"
steht unter der journalistisch-redaktionellen Verantwortung von

Pronova BioPharma ASA (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Presentation at the SEB Investor Conference in Copenhagen ...

TAK-085 Entered into Phase 3 Clinical Programs ...

December 14, 2009, Osaka, Japan and Lysaker, Norway --- Takeda Pharmaceutical Company Limited (Osaka, Japan, "Takeda") and Pronova BioPharma ASA (OSE: PRON.OL) (Lysaker, Norway, "Pronova") today announced that the advancement of T ...

Financial calender 2010 for Pronova BioPharma ASA ...

FINANCIAL CALENDAR 2010 Pronova BioPharma ASA (PRON) Lysaker, 7 December 2009: 12 February 2010: FY 2009 Results 7 May 2010: Results 1Q 2010 7 May 2010: Annual General Meeting 13 August 2010: Results 2Q 2010 12 November 2010: Results 3Q 2010 Al ...

Alle Meldungen von Pronova BioPharma ASA